The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

policy: 1 policy source
twitter: 12 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 184 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

Orphanet-Italia, 14 Oct 2015

COSTO EFFICACIA E COSTO UTILITÀ DEI FARMACI ULTRA-ORFANI IN EUROPA I farmaci per le malattie ultra-orfane sono tra i farmaci…

FECOER :: Federación Colombiana de Enfermedades Raras, 04 Aug 2015

The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.